webinar alzforum dec 2012 heppner
DESCRIPTION
Presentation delivered by Dr. Frank Heppner, December 12, 2012 at the Alzheimer Research Forum live webinar titled "Neuroinflammation—A Prelude to Alzheimer's?" Review details at http://www.alzforum.org/res/for/journal/detail.asp?liveID=207TRANSCRIPT
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Distinct phenotypes of microglia/immune system actions
in the course of AD
Alzforum Webinar 12/12/12
Frank Heppner, MDDepartment of Neuropathology
Charité – Universitätsmedizin Berlin
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Distinct functions of microglia in the course of AD
microglia (Iba-1)Aβ (4G8)
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
APPPS1
APPPS1-TK+APPPS1-TK -
CD11b-HSVTK
X
Ganciclovir application for 4 weeks
No change in Aβ plaque load in APPPS1-TK mice upon ablating > 95% microglia for up to 30 days
Co
ng
o R
edIb
a1/C
on
go
Red
Heppner et al., Nature Medicine 2005Grathwohl, Kälin et al., Nature Neuroscience 2009
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Why?
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Are microglia in AD brains really normal?
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Krabbe, Halle et al., submitted
No, they aren’t:
•Impaired microglial response to acute tissue lesions in plaque-carrying APPPS1 mice – 2P realtime imaging
• Impaired microglial phagocytosis of latex beads in APPPS1 mice in the presence of Aβ
And, notably:
•rescue of microglial phagocytosis activity upon Aβ vaccination-based Aβ reduction
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Further phenotyping microglia in AD:Upregulation of microglial IL-12/23p40 in APPPS1 mice
Vom Berg, Prokop et al., Nature Medicine 2012
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Drastic reduction of Aβ plaque load in APPPS1 mice lacking IL-12 and / or IL-23
Vom Berg, Prokop et al., Nature Medicine 2012
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Drastic reduction of Aβ plaque load in APPPS1 mice lacking IL-12 and / or IL-23
Vom Berg, Prokop et al., Nature Medicine 2012
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Conclusions
Phenotypes of microglia in AD
1. Dysfunction (i.e. lack of function) of microglia in APPPS1 mice over time, possibly due to chronic Aβ exposure and/or to chronic inflammatory microenvironment
Temporary ablation of microglia (up to 30 days) „doesn‘t matter“ (longer periods have not been tried due to technical limitations of the model)
Does AD pathology exacerbate due to the lack of microglia function?
However: microglia phenotype is reversible (e.g. by means of Aβ vaccination)!
2. (over)production of cytokines, including IL-12 and IL-23, which exacerbate
AD-like pathology
Blocking of IL-12/23 (genetically, or pharmacologically for at least 60 days) results in alleviation of AD-like pathology (plaque burden, behaviour)
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Conclusions
• It very much depends, when certain (microglial) immune molecules act, and for how long they act
• In turn, it matters, which specific immune components will be manipulated, when and for how long
• Thus, we need to dissect the impact of distinct immune components in more detail. There is no such thing as exclusively „good“ or „bad“ microglia /„the immune reaction“ in AD
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Institut für Neuropathologie
Department of Cellular NeurologyHertie-Institute of
Clinical Brain ResearchUniversity of Tübingen
Mathias JuckerStefan Grathwohl
Institut für Experimentelle Immunologie
Universitätsspital Zürich
Burkhard BecherJohannes vom Berg
funded byNIH (NINDS R01 NS046006)
NeuroCure excellence cluster (DFG)EU FP7 HEALTH (Project LUPAS)
Kompetenznetzes Degenerative Demenzen (BMBF)SFB TRR 43 (DFG)
Helmut KettenmannGrietje Krabbe
Max Delbrück Center for Molecular Medicine
Berlin
Department of NeuropathologyCharité – Universitätsmedizin Berlin
Annett HalleCaesarBonn
Heppner lab:
Ulrike BernhardtJohannes von Büren
Natalia DrostGina Eom
Claire GehlhaarSusann HandrickNicole Henschel
Roland Kälin Kerstin KoppStefanie Kraft
Petra MatylewskiKelly MillerRay Monk
Juliane ObstDebora Pehl
Stefan ProkopBianca Richter
Jan Leo RinnenthalCarola Schipke
Lisa WagnerAnja Wegner
Gordon Wilke